Shawn Khorrami from Khorrami Pollard & Abir, LLP, has been appointed to serve on the national Plaintiff Steering Committee for the Multi District Litigation pending in the Eastern District of Arkansas for Hormone Therapy, including Prempro and Premarin. The Firm has undertaken national prosecution of cases involving Hormone Replacement Therapy including Prempro and Premarin both as class actions and individual personal injury cases.

Prempro (a combination of estrogen and progestin) is a leading hormone replacement therapy drug. It is prescribed for the treatment of postmenopausal symptoms. Recent studies show long term use of Prempro may increase risks of strokes, heart attacks, blood clots, and breast cancer. The results from this study were so severe that the NIH-National Institute of Health ceased their experiments due to a fear that their participants may be at risk.

Concluding the hormones' risks outweighed those benefits, the NIH stopped the 16,600-woman study three years early - and is advising other women who use the estrogen-progestin combination to ask their doctors if they, too, should quit.

If you or a loved one have taken Prempro or Premarin, you may have a right to make a claim for damages.

To fully explore your rights you are advised to contact Khorrami Pollard & Abir, LLP, who is interested in prosecuting class actions and individual injury actions against the manufacturer. We are capable of servicing clients from coast to coast. For further information and free consultation, please contact us either electronically or by telephone.